UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Advanced Stage, Increased Lactate Dehydrogenase, and Primary Site, but Not Adolescent Age (≥ 15 Years), Are Associated With an Increased Risk of Treatment Failure in Children and Adolescents With Mature B-Cell Non-Hodgkin's Lymphoma: Results of the FAB LMB 96 Study

Journal of clinical oncology, 2012-02, Vol.30 (4), p.387-393

2012

Volltextzugriff (PDF)

Clofarabine monotherapy in aggressive, relapsed and refractory Langerhans cell histiocytosis

British journal of haematology, 2024-05, Vol.204 (5), p.1888-1893

2024

Volltextzugriff (PDF)

Recent molecular and therapeutic advances in B‐cell non‐Hodgkin lymphoma in children

British journal of haematology, 2016-05, Vol.173 (4), p.531-544

2016

Volltextzugriff (PDF)

Mixed Phenotype Acute Leukemia, B/Myeloid (Bilineal and Biphenotypic), With t(2;22)(q35;q12);EWSR1-FEV

Journal of pediatric hematology/oncology, 2021-04, Vol.43 (3), p.e388-e394

2021

Volltextzugriff (PDF)

Excellent outcomes in children and adolescents with CNS+ Burkitt lymphoma or other mature B‐NHL using only intrathecal and systemic chemoimmunotherapy: results from FAB/LMB96 and COG ANHL01P1

British journal of haematology, 2019-04, Vol.185 (2), p.374-377

2019

Volltextzugriff (PDF)

Ibrutinib significantly inhibited Bruton's tyrosine kinase (BTK) phosphorylation,in-vitro proliferation and enhanced overall survival in a preclinical Burkitt lymphoma (BL) model

Oncoimmunology, 2019-01, Vol.8 (1), p.e1512455-e1512455

2019

Volltextzugriff (PDF)

A randomized comparison between rasburicase and allopurinol in children with lymphoma or leukemia at high risk for tumor lysis

Blood, 2001-05, Vol.97 (10), p.2998-3003

2001

Volltextzugriff (PDF)

686 Targeted immunotherapy and checkpoint blockade in children, adolescents, and young adults with lymphoma: RADICAL hodgkin cohort

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A779-A779

2023

Volltextzugriff (PDF)

Diagnosis and management of mature B-cell lymphomas in children, adolescents, and young adults

Best practice & research. Clinical haematology, 2023-06, Vol.36 (2), p.101463-101463, Article 101463

2023

Volltextzugriff (PDF)

Overall survival of children and adolescents with mature B cell non‐Hodgkin lymphoma who had refractory or relapsed disease during or after treatment with FAB/LMB 96: A report from the FAB/LMB 96 study group

British journal of haematology, 2018-09, Vol.182 (6), p.859-869

2018

Volltextzugriff (PDF)

Rasburicase: potential role in managing tumor lysis in patients with hematological malignancies

Expert review of anticancer therapy, 2003-08, Vol.3 (4), p.429-433

Goldman, Stanton C

2003

Volltextzugriff (PDF)

Translocation (4;19)(q35;q13.1)–Associated Primitive round Cell Sarcoma: Report of a Case and Review of the Literature

Pediatric and developmental pathology, 2008-05, Vol.11 (3), p.239-244

2008

Volltextzugriff (PDF)

Multicenter Pilot Trial of Intrathecal Liposomal Cytarabine Combined with FAB Chemoimmunotherapy with Reduced Doxorubicin in CAYA with Mature De-Novo B-NHL

Blood, 2023-11, Vol.142 (Supplement 1), p.1727-1727

2023

Volltextzugriff (PDF)

Understanding of Severe Combined Immunodeficiency and Carrier Status in the U.S.-Based Irish Traveller Population

Clinical immunology (Orlando, Fla.), 2023-05, Vol.250, p.109378, Article 109378

2023

Volltextzugriff (PDF)

Rituximab with chemotherapy in children and adolescents with central nervous system and/or bone marrow‐positive Burkitt lymphoma/leukaemia: a Children's Oncology Group Report

British journal of haematology, 2014-11, Vol.167 (3), p.394-401

2014

Volltextzugriff (PDF)

Phase I/II dose escalation study of recombinant human interleukin‐11 following ifosfamide, carboplatin and etoposide in children, adolescents and young adults with solid tumours or lymphoma: a clinical, haematological and biological study

British journal of haematology, 2005-01, Vol.128 (1), p.49-58

2005

Volltextzugriff (PDF)

Targeted Immunotherapy and Checkpoint Blockade in Children, Adolescents, and Young Adults with Lymphoma: Radical Hodgkin Cohort

Blood, 2023-11, Vol.142 (Supplement 1), p.3083-3083

2023

Volltextzugriff (PDF)

Diagnostic and Therapeutic Challenges for Infants with Radiosensitive (RS)-SCID Identified by Newborn Screening (NBS)

Journal of allergy and clinical immunology, 2022-02, Vol.149 (2), p.AB25-AB25

2022

Volltextzugriff (PDF)

Rasburicase in the prevention of laboratory/clinical tumour lysis syndrome in children with advanced mature B‐NHL: a Children's Oncology Group Report

British journal of haematology, 2013-11, Vol.163 (3), p.365-372

2013

Volltextzugriff (PDF)

Outcome and pathologic classification of children and adolescents with mediastinal large B-cell lymphoma treated with FAB/LMB96 mature B-NHL therapy

Blood, 2013-01, Vol.121 (2), p.278-285

2013

Volltextzugriff (PDF)

Polatuzumab Vedotin, an Antibody-Drug Conjugate Targeting CD79b, Is a Highly Active Agent Against Burkitt Lymphoma and Primary Mediastinal B-Cell Lymphoma

Blood, 2019-11, Vol.134 (Supplement_1), p.3963-3963

2019

Volltextzugriff (PDF)

Patient Selection and Treatment of Tumor Lysis Syndrome in Adults with Hematologic Malignancies

Supportive cancer therapy, 2005-04, Vol.2 (3), p.167-167

Goldman, Stanton C.

2005

Volltextzugriff (PDF)

Comparative genomic expression signatures of signal transduction pathways and targets in paediatric Burkitt lymphoma: a Children's Oncology Group report

British journal of haematology, 2017-05, Vol.177 (4), p.601-611

2017

Volltextzugriff (PDF)

Excellent outcomes in children and adolescents with CNS + Burkitt lymphoma or other mature B‐ NHL using only intrathecal and systemic chemoimmunotherapy: results from FAB / LMB 96 and COG ANHL 01P1

British journal of haematology, 2019-04, Vol.185 (2), p.374-377

2019

Volltextzugriff (PDF)

1 – 25 von 77

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(68)
Mit Volltextzugriff
(66)

Publikationsform

Sprache

Englisch
(77)

Erscheinungsjahr

n.n

Thema

Science & Technology
(32)
Life Sciences & Biomedicine
(31)
Humans
(30)
Male
(19)
Female
(18)
Hematology
(18)
Adolescent
(16)
Child
(16)
Biological And Medical Sciences
(12)
Medical Sciences
(12)
Adult
(11)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(9)
Child, Preschool
(9)
Oncology
(9)
Infant
(8)
Young Adult
(8)
Chemotherapy
(7)
Children
(7)
Lymphoma, B-Cell - Drug Therapy
(7)
Antineoplastic Combined Chemotherapy Protocols - Administration & Dosage
(6)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Advanced Stage, Increased Lactate Dehydrogenase, and Primary Site, but Not Adolescent Age (≥ 15 Years), Are Associated With an Increased Risk of Treatment Failure in Children and Adolescents With Mature B-Cell Non-Hodgkin's Lymphoma: Results of the FAB LMB 96 Study

Clofarabine monotherapy in aggressive, relapsed and refractory Langerhans cell histiocytosis

Recent molecular and therapeutic advances in B‐cell non‐Hodgkin lymphoma in children

Mixed Phenotype Acute Leukemia, B/Myeloid (Bilineal and Biphenotypic), With t(2;22)(q35;q12);EWSR1-FEV

Excellent outcomes in children and adolescents with CNS+ Burkitt lymphoma or other mature B‐NHL using only intrathecal and systemic chemoimmunotherapy: results from FAB/LMB96 and COG ANHL01P1

Ibrutinib significantly inhibited Bruton's tyrosine kinase (BTK) phosphorylation,in-vitro proliferation and enhanced overall survival in a preclinical Burkitt lymphoma (BL) model

A randomized comparison between rasburicase and allopurinol in children with lymphoma or leukemia at high risk for tumor lysis

686 Targeted immunotherapy and checkpoint blockade in children, adolescents, and young adults with lymphoma: RADICAL hodgkin cohort

Diagnosis and management of mature B-cell lymphomas in children, adolescents, and young adults

Overall survival of children and adolescents with mature B cell non‐Hodgkin lymphoma who had refractory or relapsed disease during or after treatment with FAB/LMB 96: A report from the FAB/LMB 96 study group

Rasburicase: potential role in managing tumor lysis in patients with hematological malignancies

Translocation (4;19)(q35;q13.1)–Associated Primitive round Cell Sarcoma: Report of a Case and Review of the Literature

Multicenter Pilot Trial of Intrathecal Liposomal Cytarabine Combined with FAB Chemoimmunotherapy with Reduced Doxorubicin in CAYA with Mature De-Novo B-NHL

Understanding of Severe Combined Immunodeficiency and Carrier Status in the U.S.-Based Irish Traveller Population

Rituximab with chemotherapy in children and adolescents with central nervous system and/or bone marrow‐positive Burkitt lymphoma/leukaemia: a Children's Oncology Group Report

Phase I/II dose escalation study of recombinant human interleukin‐11 following ifosfamide, carboplatin and etoposide in children, adolescents and young adults with solid tumours or lymphoma: a clinical, haematological and biological study

Targeted Immunotherapy and Checkpoint Blockade in Children, Adolescents, and Young Adults with Lymphoma: Radical Hodgkin Cohort

Diagnostic and Therapeutic Challenges for Infants with Radiosensitive (RS)-SCID Identified by Newborn Screening (NBS)

Rasburicase in the prevention of laboratory/clinical tumour lysis syndrome in children with advanced mature B‐NHL: a Children's Oncology Group Report

Outcome and pathologic classification of children and adolescents with mediastinal large B-cell lymphoma treated with FAB/LMB96 mature B-NHL therapy

Polatuzumab Vedotin, an Antibody-Drug Conjugate Targeting CD79b, Is a Highly Active Agent Against Burkitt Lymphoma and Primary Mediastinal B-Cell Lymphoma

Final Report of Reduced Anthracycline Dose Intensity with the Addition of Dose Dense Rituximab in Children, Adolescents and Young Adults with De Novo Good Risk Mature B-Cell Non Hodgkin Lymphoma (B-NHL)

Patient Selection and Treatment of Tumor Lysis Syndrome in Adults with Hematologic Malignancies

Comparative genomic expression signatures of signal transduction pathways and targets in paediatric Burkitt lymphoma: a Children's Oncology Group report

Excellent outcomes in children and adolescents with CNS + Burkitt lymphoma or other mature B‐ NHL using only intrathecal and systemic chemoimmunotherapy: results from FAB / LMB 96 and COG ANHL 01P1

Suchergebnisse filtern